Regulatory Open Forum

 View Only
Expand all | Collapse all

complaint handling / MDR

  • 1.  complaint handling / MDR

    Posted 19-Apr-2016 17:43

    Hi all. I am assisting a company w/ their complaint handling & medical device reporting process. Class II devices. I have run into a couple of roadblocks & would like your opinions.

    As I was reviewing their complaint log, I noticed complaints describing burning sensations, irritations, rashes, infections, etc. I feel that these events should be reported, but the employee in charge of the project does not want to report any adverse events unless the customer actually goes to his or her physician because of it. His rationale is that if the condition eventually resolves on its own, or if the customer never went to the doctor because of it, then "it must not have been serious." While I understand his position, I disagree. Perhaps I have just worked for extremely conservative companies in the past, but these types of events would have always been considered reportable events in all of my prior companies. My rationale is that we are not physicians, & are therefore not qualified to make the determination of how serious an injury may/may not be. Further to that, I feel that we should report based on the fact that the same type of event may be more serious depending on the individual should it reoccur. I'd love to hear your opinions.

    Another problem that I have discovered is that some of their devices which are currently on the market do not have the required 510(k) clearances. The owner assures me that they are working towards getting them, but as of yet, they are not cleared. So my dilemma is whether to suggest that they file MDRs for complaints involving these uncleared devices or not. Their concern is that doing so may draw attention from FDA before they get   510(k) approvals.  I certainly can understand where they are coming from, but I am equally as concerned, if not more so, about not reporting events concerning these devices. Have any of you faced a similar situation, and if so, what would you suggest? Essentially, which is the "lesser of two evils" so to speak? The owners would like to know which is riskier to the company, etc. 

    I appreciate everyone's feedback. Have a great afternoon!

    ------------------------------
    Lauren Parker
    CA
    United States
    ------------------------------


  • 2.  RE: complaint handling / MDR

    Posted 19-Apr-2016 18:15
    Lauren,

    When I travel to client's site, I usually leave my heart in my car so that I can better keep my BP steady-state no matter what! 

    MDR issue

    Each incident should be evaluated under surrounding circumstances.  It seems the firm has set criteria (rashes, infection, irritation, etc.) as "not serious injury" unless medical intervention was necessary (e.g. going to the office).  Generally speaking, that is acceptable unless such event can lead to complications/serious issues.

    Some firms may also set their criteria (rashes, reaction, irritation, etc.) to be reportable to stay rather "conservative."

    510(k) clearance

    As a consultant, you can tell them marketing a device (which is subject to premarket notification) can be cited during FDA inspection. It is recommended to submit a 510(k) to FDA. The sooner the better.

    But then with no willingness, it may/can not happen. Please sense their emotional temperature in view of business operation.

    Under the surrounding circumstances, you may also help them document so that they can submit their 510(k) anytime sooner upon FDA inspection.  

    Thank you.  

    s/ David
    ______________________________________________
    Dr. David Lim, Ph.D., RAC, ASQ-CQA 
    Phone (Toll-Free): 1-(800) 321-8567



    "Knowledge is power only when it is practiced and put into action." - Regulatory Doctor

    NOTICE: This communication (including any attachments) may contain privileged or confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this communication and/or shred the materials and any attachments and are hereby notified that any disclosure, copying or distribution of this communication, or the taking of any action based on it, is strictly prohibited.





  • 3.  RE: complaint handling / MDR

    Posted 19-Apr-2016 18:48

    Thanks David. I used to manage the adverse event handling unit at a large company. In every training I can remember, we were told that "intervention" does not necessarily mean "medical intervention given by a physician." Intervention could literally be as simple as applying a topical treatment at home. Let's use an extreme example. Suppose that while using a medical device, I accidentally amputate my finger. I could say, "Meh, just a pinky. I've got nine more fingers" then clean it, wrap it up & be done with it (again, extreme example), while another person may rush to the hospital & go through a surgery, reattachment, recovery & physical therapy. While I don't think anyone would argue that this would be a serious injury, the response of the individual may vary drastically. Therefore, I don't feel that setting criteria for non-serious events based on the type of event/injury itself is effective or appropriate. There are also many reasons people may not see a physician for what they know to be a serious injury (financial reasons, mental capacity, fear of losing job, etc.) which must be considered. In response to your statement, "that is acceptable unless such event can lead to complications/serious issues", I agree, but not being a physician, I do not feel qualified to state whether or not these events could lead to more serious complications or further injury. For example, there are many rashes that are essentially harmless, while others can be life-threatening. Without having the ability to diagnose this, I cannot say that this may not lead to something far more serious, if not for the individual concerned, perhaps to another person that may experience the same/similar event. I hope that makes sense.

    As for my 510(k) question, I have already advised them all of the things that you have suggested. My question is strictly regarding reporting/not reporting adverse events involving the unapproved devices. 

    Thanks so much for the feedback so far.

    ------------------------------
    Lauren Parker
    CA
    United States



  • 4.  RE: complaint handling / MDR

    Posted 19-Apr-2016 19:11
    Lauren,

    Your post is loaded with valid points.

    I will address few points.

    The "medical intervention" may also include use of antibiotics.  A diabetic sticks a finger with lancet.  S/he claims "I got an infection" with your lancet.  A firm may report this even after firm's investigation reveals allegation is unverifiable. 

    Under FDA's patient problem codes, those symptoms you mention can be reportable. 

    As I mention, each incident needs to be evaluated on a case by case.

    In some cases, physician's opinion can be used and is important for better defending for product liability claims.

    Please be noted that under the surrounding circumstances, the same  symptom may or may not be reportable.  

    To apply reportability consistently, setting general criteria based on firm's profile of complaints in view of device types is important.  

    It seems you may have said enough to them. 

    I would recommend you please let them consider all your advice and decide!  

    D





  • 5.  RE: complaint handling / MDR

    Posted 20-Apr-2016 10:08

    Dear Lauren,

    1 . MDR - Agree with Dr. Lim

    2. 510(k) - If caught your client is subject to product recall due to misbranding.  Technically the product should not be sold yet, as you know.  I have been subject to a recall by the FDA and been caught in this situation.  Get your client's 510(k) submitted ASAP or exercise a correction and removal for the labels immediately to remove all medical device claims.  Change the label to remove medical device claims immediately until you have the 510(k) approval(s).

    ------------------------------
    Hollie Johnson
    732-403-4681



  • 6.  RE: complaint handling / MDR

    Posted 19-Apr-2016 21:23
    Edited by Kevin Randall 19-Apr-2016 21:43

    The essence of your question boils down to whether or not the MDR threshold for “serious injury” is met by descriptors such as “burning sensations”, “irritations”, “rashes”, “infections”, etc.  It may be that your coworker is basing his opinion on the third arm of FDA’s “serious injury” threshold, which speaks to injury or illness that necessitates medical or surgical intervention to preclude permanent impairment of a body function or permanent damage to a body structure.

     

    Regardless, 21 CFR 803.20(c) basically dictates the manner in which “serious injury” decision-making is to happen.  Therefore your team needs to carefully attend to the intent and implications of 803.20(c).

     

    In a nutshell, 803.20(c) states that the “serious injury” decision needs to be anchored by the insights of a person qualified to make a medical judgment.  The FDA says that this means a physician, nurse, risk manager, or biomedical engineer.  Therefore, you showed great wisdom when you noted the importance of being medically-qualified to judge how serious an injury may/may not be.

     

    Firms also need to be aware that the Agency has had a history of heavily weighting the impressions and opinions voiced by device users when those users are themselves people qualified to make a medical judgment.  For example, the original 1984 MDR regulations and preamble included a “per se” rule whereby if a user qualified to make a medical judgment informed the manufacturer that a reportable event occurred, then it in effect constituted a reportable event based solely on the fact that such a user is viewed by FDA to have, “…special education, training, experience, expertise, and knowledge with respect to medical devices…”  Although the “per se” rule was stricken in 1996, I for one remain cognizant of this because my experience has been that this general thought process persists in the minds of FDA inspectors.

     

    So at the end of the day, if a firm receives complaints alleging injuries/illnesses such as “burning sensations”, “irritations”, “rashes”, “infections”, etc., even if apparently minor, then the ultimate designation of “serious injury” (and especially lack of serious injury) needs to be based on input from a person qualified to make a medical judgment, AND who has made his/her judgment in the direct context of the intended use and technology for the particular subject device.  Without such a basis, the manufacturer leaves itself vulnerable to compliance and safety pitfalls because, contrary to FDA’s requirements, such a basis isn’t based on qualified professional, scientific, or medical facts, observations, or opinions.

     

    I’ve observed the integration of qualified medical judgement in practice at multiple firms and clients, large and small, where qualified medical advisory reviewers were included in the review and sign-off of the MDR reportability decision.  While this may seem overly burdensome, MDR reportability assessments are not the place to cut corners, as failure to submit required MDR reports is one of FDA’s Warning Letter triggers.

     

    Hope this helps,

    ------------------------------
    Kevin Randall RAC (U.S., Canada, Europe)
    Principal Consultant
    ComplianceAcuity, Inc.
    Golden CO
    United States

    Copyright 2016 by ComplianceAcuity, Inc.  All rights reserved.





  • 7.  RE: complaint handling / MDR

    Posted 20-Apr-2016 10:30

    I agree with Kevin, that is how we assess whether we will report or not.  We have a Potentially Reportable Events Committee that assess each event and a Clinician is on this committee to help in the assessment.   

    Depending on the type of medical device, a rash or irritation doesn't seem too serious, but someone qualified to make this decision should be making this decision and perhaps Risk Management should be consulted as well. 

    Honestly, I am kind of wondering if a lot of companies don't have this type of assessment because when I go through the MAUDE database for post market surveillance I see a lot of things that are reported that seem very minor are would not be considered reportable on our end.  I'm not sure many of them would ever meet FDA's definition of serious injury. It is a waste of time and resources, in my opinion, to report these.




  • 8.  RE: complaint handling / MDR

    Posted 20-Apr-2016 10:42
    Carrie,

    "I see a lot of things that are reported that seem very minor are would not be considered reportable on our end."

    I've observed there are significant variations in many firms' complaint/MDR procedures, potentially leading to your observation from the database. 

    One extreme example: death

    Death is not always reportable. Whether it (death) meets MDR criteria or not, surrounding circumstances should be considered and evaluated in connection with terms "caused" or "contributed to"

    If the device may not have caused or contributed to death or if the device may not have been a factor to death, then death is not reportable. 

    What firms often don't do:  they seem to underestimate the importance of collecting info on patient symptoms, medical history, all surrounding circumstances, etc.

    It is not about pushing "MDR button" but rather it should be about why we push "MDR button." 

    Thank you.  

    s/ David
    ______________________________________________
    Dr. David Lim, Ph.D., RAC, ASQ-CQA 
    Phone (Toll-Free): 1-(800) 321-8567



    "Knowledge is power only when it is practiced and put into action." - Regulatory Doctor

    NOTICE: This communication (including any attachments) may contain privileged or confidential information intended for a specific individual and purpose, and is protected by law. If you are not the intended recipient, you should delete this communication and/or shred the materials and any attachments and are hereby notified that any disclosure, copying or distribution of this communication, or the taking of any action based on it, is strictly prohibited.





  • 9.  RE: complaint handling / MDR

    Posted 19-Apr-2016 21:39
    Edited by Kevin Randall 19-Apr-2016 21:41

    As for your MDR reporting of un-cleared devices question, I can circle back later with a more detailed answer if needed.  But obviously, it increases the immediate compliance risk to the firm if it submits MDR reports for un-cleared devices.  For example, the FDA product code [which is officially assigned and finalized as part of 510(k) clearance] is a required element of FDA's MAUDE database entry, which would be one of multiple possible signals to FDA that the subject device is not cleared...

    ------------------------------
    Kevin Randall RAC (U.S., Canada, Europe)
    Principal Consultant
    ComplianceAcuity, Inc.
    Golden CO
    United States



  • 10.  RE: complaint handling / MDR

    Posted 20-Apr-2016 01:11
    Edited by Kevin Randall 20-Apr-2016 01:17

    Getting back to your question about “which is the ‘lesser of two evils’"…

     

    It's a risky proposition to do anything other than fully comply with the MDR regulations AND the 510(k) requirements. Indeed, by my unofficial data gleaned from FDA’s Warning Letter database, failure to comply with MDR requirements and failure to submit a 510(k) appear to be cited in Warning Letters at roughly equivalent frequencies, yet with MDR violations occurring slightly more often. So for this case, the “lesser of two evils” would seem to be to decide that BOTH are equally risky. While some compliance scenarios are great candidates for risk/benefit analysis, MDR vs. 510(k) is more of a “give your right leg or your left leg” situation where there will probably be profound challenges either way.

     

    However, it may help your decision-making to remember that FDA’s prime directive is to protect the public health. Consequently, the Agency’s enforcement practices are, as a general rule, dictated accordingly. So in a world of limited resources, FDA is forced to deploy its limited resources commensurate with risk. Likewise, every device firm needs to deploy its own limited resources by weighing out the risks and benefits of how its own decisions impact the public health.

     

    So then, which has a greater impact on public health: MDR compliance or section 510(k)? My experience in inspection and remediation projects has been that FDA enforcers seem to get more riled up about MDR compliance. Similarly, FDA’s IOM and RPM allow District FDA investigators/offices to autonomously cite MDR violations (including failure to submit an MDR “serious injury” report) in FDA-483’s and Warning Letters. In contrast, CDRH (“Center”) concurrence (i.e., administrative/bureaucratic rigmarole encumbering enforcement gestures) is generally required before 510(k) clearance violations can be recorded on an FDA-483 or in a Warning Letter. Consequently, although each compliance situation needs to be carefully considered based on its own merits, the FDA’s (i.e., our public health Agency’s) own internal operating procedures seem to place a greater urgency on more timely/streamlined resolution of MDR reporting problems in comparison to 510(k) violations. This seems to make sense given that adverse events involve clear and present safety issues, whereas 510(k) violations do not directly indicate the presence of an existing safety issue.

     

    But in the end, neither MDR reporting nor 510(k) compliance issues are insignificant from any perspective, be it business, public health, compliance, or otherwise. So in this type of instance, it is not appropriate for the compliance Manager/Director (or any other person at that organizational level) to make the final decision alone. Instead, each firm’s Executive Management needs to receive full counsel on such matters, and then Executive Management needs to make the ultimate decision. And remember that “Executive Management” is oftentimes someone who must answer to a Board of Directors or Investors, and/or is the Owner/Founder who has invested heavily in the business. Accordingly, proper sensitivity to that dynamic is strongly advised when dealing with weighty topics like MDR reporting, recalls, and premarket clearance/approval.

     

    Hope this helps,

    ------------------------------
    Kevin Randall ASQ CQA, RAC (U.S., Canada, Europe)
    Principal Consultant
    ComplianceAcuity, Inc.
    Golden CO
    United States

    Copyright 2016 by ComplianceAcuity, Inc. All rights reserved.



  • 11.  RE: complaint handling / MDR

    Posted 20-Apr-2016 08:40

    Hi Lauren.

    My initial thought on the first problem (the MDR issue itself regarding the requirements of when a report is required) is that a reported event is a reportable event in general and then it is up to the company to prove why it is not reportable.  For example, your company receives a report of a potentially serious adverse event with the device.  First, you must understand WHO is reporting the event.  If it is the user, then further questions need to be considered regarding the reportability issue.  If it is a physician than I think Kevin's point is important in that the fact that the physician determined it was reportable to the company means that it is in the physician's opinion reportable to FDA since physicians typically don't waste time reporting things they feel are not significant.  But the pitfall here is that your client likely has no information on the background or education/training of the reporter if the injury is reported by a user.  It is still reasonably possible that the user is medically trained and is reporting the issue personally rather than going to their own physician since they are able to make the medical judgment.  So I tend to be a bit more cautious in determining what should be reported and what is not required.  I think the point that Kevin made regarding the review by someone with medical training within the company or on a consulting basis is really something that needs to be considered by your client.  Without the sign off by someone uniquely qualified to determine the severity of the injury it is going to be difficult to defend the company if FDA determines that something should have been reported.  More importantly it might be easier to obtain further information from the reporter through a contact with medical personnel than through someone on your complaint handling team because the questions being asked by medical personnel will tend to be more to the point and will provide the user/reporter with potentially more complete context within which to provide the answers needed to make a sound medical decision on the severity of the injury.

    The issues with the uncleared devices are more intriguing.  First, the fact that these devices are in commerce already has immediately opened the client to immediate action from FDA at any point that FDA discovers the issue.  This is true even if the device is cleared and only later it becomes known to the agency that the device was in commerce prior to approval.  So in my mind the reporting of the adverse events is likely to lead to more immediate action by the agency.  That is not to say that waiting to report these events until the product is cleared is viable either since there are expectations on transparency and speed of reporting these events.  So let's take an example for explaining the ultimate question and possible argument.  If and when (because we all know it is going to happen - thanks to some guy named Murphy who didn't lead a very charmed life!) FDA comes into the business on an inspection and asks for the device complaint log (as you obviously did) they are going to find that the company has X devices cleared and Y devices on their complaint log.  The next logical question is going to be what are all of these other devices and do you have clearance for them to be marketed?  When your client says they are ________ and the inspection teams determines that they qualify as Class II 510(k) devices, and that your company has not reported the adverse events according to the requirements of the regulation, your client might as well set up a conference room for FDA to settle down in because they are likely to be there for a good long while and nothing good is going to come out of that inspection.  Every system and every decision is likely to be scrutinized to agonizingly microscopic levels and there is going to be a very difficult inspection along with potential requirements to recall any and all devices on the market that have not yet been cleared.  I also could see a more significant review of any 510(k) that is submitted after that inspection where the FDA finds the devices that have not been cleared but are being marketed.  Also remember that this is likely to draw at a minimum a warning letter from the agency and that the agency has every right to hold approval of your client's currently pending and yet to be submitted applications until all of the issues involved in the warning letter are completely fixed to the FDA's satisfaction.  So really, your client needs to get the 510(k) documentation into FDA and get that started now.  This will at least mitigate the size and severity of the reaction from the FDA but again it is still likely to draw a warning letter in the future even after the items have been cleared since the complaint log is still going to show distribution of an uncleared device.

    ------------------------------
    Victor Mencarelli
    Sr. Manager - Regulatory Affairs
    Hain Celestial Group
    United States



  • 12.  RE: complaint handling / MDR

    Posted 20-Apr-2016 20:41

    Scary … this situation has all the earmarks of a company with some very serious problems. Lauren, I suspect you already sense this.
    FDA would see this as: A device that is not legally marketed and is encountering (causing?) adverse events, some of which are potentially reportable, but are not. Wow … instant Warning Letter! In my experience in such situations, there is a strong possibility that there are other serious GMP violations (Design Control?, Validations? Internal Audits? Etc?) and the UDI deadline is fast approaching.

    If any of the above is true, then immediate fixes are in order; a significant effort now or even bigger and more costly effort after the WL.

    Just my 2 cents,

    Art

     






  • 13.  RE: complaint handling / MDR

    Posted 20-Apr-2016 21:37
    Edited by Lin Wu 20-Apr-2016 21:40

    What is the type of device, a skin patch or an implant?  

    A device caused "infection" could be serious injury, for example, an implant caused "pelvic infection" could lead to toxic shock and death of the patients without medical intervention.  I echo Carrie's discussion that during the evaluation of compliant report-ability, one of the members of the company's review committee should be a medical doctor.

    I suggest also to take a look of the company's compliant handling procedure - is the procedure adequate?  Or if the procedure adequate, is it followed by the company?  The company may receive warning letter like this below example:

    "3.    Failure to adequately develop, implement, and maintain written MDR procedures, as required by 21 CFR 803.17 (Arvada facility). For example:

     
    Your firm’s MDR procedure, “Standard Operating Procedure for Medical Device Reporting”, (b)(4), Rev. AA, updated on October 15, 2012, has the following deficiencies:
     
    a.    The procedure does not establish internal systems that provide for timely and effective identification, communication, and evaluation of events that may be subject to MDR requirements. For example, the procedure omits definition of the term “reasonably suggests,” found in 803.20(c)(1). The exclusion of this definition for this term from the procedure may lead your firm to make an incorrect reportability decision when evaluating a complaint that may meet the criteria for reporting under 21 CFR 803.50(a);"

    ------------------------------
    Lin Wu RAC
    Waltham MA
    United States



  • 14.  RE: complaint handling / MDR

    Posted 21-Apr-2016 12:38

    I’m interested in the decision not to file an MDR for a legally marketed device. (The decision for other devices has additional complexity that I will consider in a different post.) While I would report, these, let’s give the benefit of the doubt to the decision maker, and explore the required quality records.

    The report comes in, is evaluated and classified as a complaint. At this point it should be evaluated for certain factors that require an investigation. Because it involves an injury, it is potentially reportable as an MDR under 820.198(a)(3). Consequently, there should be an investigation conducted by a designated individual under 820.198(d). The record of investigation includes the elements in both 820.198(e) and 820.198(d). Hint: Ensure the investigation decision is documented, the investigator is designated (quality record), is trained for the designated work (quality record), and the results of the investigation are documented (quality record).

    Because this is a potentially reportable event, there should be an MDR Event File, 803.18, that links to the complaint file. The MDR Event File contains an the results of the evaluation of the event and and an explanation of why it was not reported, 803.20(e).

    The decision not to report must be made by a qualified person and the MDR Event File must contain the information to support the decision that the event was not reportable. Hint: Ensure the decision not to report is documented (quality record), the investigator is qualified (quality record).

    While the FDA Investigator may not agree with the decision, the lack of a decision making process and the associated records would generate a Warning Letter on its own.

    ------------------------------
    Dan O'Leary
    Swanzey NH
    United States



  • 15.  RE: complaint handling / MDR

    Posted 23-Apr-2016 06:44

    Let me address your second problem. The company is marketing a 510(k) device without clearance, and is receiving reports of patient harm. This is a serious problem for you. Your advice should be to stop marketing the product. Then patient harm reports and MDR filing are no longer a problem.

    If patients are being harmed, then you should expect a product liability suit. When that happens, the company will turn over records as part of discovery. The attorney will then bring in an expert witness to review all the documentation. In addition, the people involved will be deposed. One way or another, you will become a party to the suit, and the advice you give will be a factor. I doubt that you or your client will prevail; this could cost you significantly.

    I’m not an attorney, but have been an expert witness in medical device law suits. My advice is to write a letter to the company owner explaining the situation and stating that you can no longer be involved until FDA has issued all the clearance letters. If that is not an approach for you, then document your recommendations in writing to create a record of good intent and attempt to resolve the situation. This will help you in your deposition. Lacking that, keep contemporaneous notes of all the activities and your recommendations. Get a notebook with bound numbered pages, such as the type used for laboratory notebooks. It will be valuable when you have to turn it over as part of discovery.

    ------------------------------
    Dan O'Leary
    Swanzey NH
    United States



  • 16.  RE: complaint handling / MDR

    Posted 10-May-2016 14:32

    Considering that these unreported adverse events are present for Neonatal products, and the FDA considers neonates a "vulnerable" population, this lack of reporting and clearance is particularly egregious.  Hopefully the investigations into cause, and the resultant actions are robust and validated.

    I agree with previous commenters, that documentation to the highest official in the company clearly stating your recommendations for the organization to become compliant on both the MDR & PMN issues is crucial, as this is a Warning Letter just waiting to be written.  

    ------------------------------
    Michael Chellson RAC